Page 205 - Read Online

Borniger. J Cancer Metastasis Treat 2019;5:23 I http://dx.doi.org/10.20517/2394-4722.2018.107 Page 15 of 18

15. Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to
block tumor growth and prolong remission. Cancer Res 2009;69:7507-11.
16. Dean GE, Redeker NS, Wang YJ, Rogers AE, Dickerson SS, et al. Sleep, mood, and quality of life in patients receiving treatment for lung
cancer. Oncol Nurs Forum 2013;40:441-51.
17. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom
Manage 2002;24:471-80.
18. Zeitlhofer J, Schmeiser-Rieder A, Tribl G, Rosenberger A, Bolitschek J, et al. Sleep and quality of life in the Austrian population. Acta
Neurol Scand 2000;102:249-57.
19. Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, et al. Changes in body fat and weight after a breast cancer
diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 2005;23:774-82.
20. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med 2002;54:1309-21.
21. Sephton SE, Lush E, Dedert EA, Floyd AR, Rebholz WN, et al. Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behav
Immun 2013;30:S163-70.
22. Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. Breast cancer and circadian disruption from electric lighting in the modern
world. CA Cancer J Clin 2014;64:207-18.
23. Borniger JC, Gaudier-Diaz MM, Zhang N, Nelson RJ, DeVries AC. Cytotoxic chemotherapy increases sleep and sleep fragmentation in
non-tumor-bearing mice. Brain Behav Immun 2015;47:218-27.
24. Bonnavion P, Mickelsen LE, Fujita A, de Lecea L, Jackson AC. Hubs and spokes of the lateral hypothalamus: cell types, circuits and
behaviour. J Physiol 2016;594:6443-62.
25. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, et al. The hypothalamus and the control of energy homeostasis: different circuits,
different purposes. Physiol Behav 2001;74:683-701.
26. Nevárez N, de Lecea L. Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation. F1000Res
2018;7:1421.
27. Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for arousal and motivation. Front Neurol 2018;9:413
28. Lecea L de, Kilduff TS, Peyron C, Gao XB, Foye PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.
Proc Natl Acad Sci 1998;95:322-7.
29. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and
G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-85.
30. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep
regulation. Cell 1999;98:437-51.
31. Crocker A, España RA, Papadopoulou M, Saper CB, Faraco J, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
Neurology. 2005;65:1184-8.
32. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, et al. Genetic ablation of orexin neurons in mice results in narcolepsy,
hypophagia, and obesity. Neuron 2001;30:345-54.
33. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
34. Geerling JC, Mettenleiter TC, Loewy AD. Orexin neurons project to diverse sympathetic outflow systems. Neuroscience 2003;122:541-50.
35. Yi CX, Serlie MJ, Ackermans MT, Foppen E, Buijs RM, et al. A major role for perifornical orexin neurons in the control of glucose
metabolism in rats. Diabetes 2009;58:1998-2005.
36. Bonnavion P, Jackson AC, Carter ME, de Lecea L. Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus
regulates stress responses. Nat Commun 2015;6:6266.
37. Goforth PB, Leinninger GM, Patterson CM, Satin LS, Myers MG. Leptin acts via lateral hypothalamic area neurotensin neurons to inhibit
orexin neurons by multiple GABA-independent mechanisms. J Neurosci 2014;34:11405-15.
38. Håkansson M, De LL, Sutcliffe JG, Yanagisawa M, Meister B. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin
neurones of the lateral hypothalamus. J Neuroendocrinol 1999;11:653-63.
39. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, et al. Increased expression of leptin and the leptin receptor as a marker of
breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006;12:1447-53.
40. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res
2004;10:4325-31.
41. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. A role for ghrelin in the central regulation of feeding. Nature
2001;409:194-8.
42. Olszewski PK, Li D, Grace MK, Billington CJ, Kotz CM, et al. Neural basis of orexigenic effects of ghrelin acting within lateral
hypothalamus. Peptides 2003;24:597-602.
43. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-13.
44. García-García F, Juárez-Aguilar E, Santiago-García J, Cardinali DP. Ghrelin and its interactions with growth hormone, leptin and orexins:
Implications for the sleep-wake cycle and metabolism. Sleep Med Rev 2014;18:89-97.
45. Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, et al. Ghrelin-induced food intake is mediated via the orexin pathway.
Endocrinology 2003;144:1506-12.
46. Au CC, Furness JB, Brown KA. Ghrelin and breast cancer: emerging roles in obesity, estrogen regulation, and cancer. Front Oncol
2017;6:265.
47. Gahete MD, Córdoba-Chacón J, Hergueta-Redondo M, Martínez-Fuentes AJ, Kineman RD, et al. A novel human ghrelin variant
(In1-Ghrelin) and Ghrelin-O-Acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance. PLoS One
2011;6:e23302.
48. Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res
2003;9:774-8.